Jeffrey Zonder, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Jeffrey Zonder, MD

Jeffrey Zonder, MD

Healthcare Professional
Medical Director
Karmanos Cancer Center
4100 John R St.
Detroit, Michigan, United States
Dr. Zonder is a Clinical Professor at Department of Oncology, Wayne State University School of Medicine. He is also a Medical Director at Apheresis Unit, Karmanos Cancer Hospital and Vice Chair at M1 IRB committee, Wayne State University. He received his medical degree from Wayne State University School of Medicine and completed residency from Primary Care Internal Medicine Residency Program, Strong Memorial Hospital. He completed fellowship in hematology/oncology at Wayne State University, Detroit Medical Center.
 
Dr. Zonder has special interest in multidisciplinary care of patients with multiple myeloma, as well as other hematologic cancers. In addition, he is focused on the investigation of therapies for multiple myeloma. His research interest includes investigation of new drug application for white cell disorders.
 
He is a member of American Society of Hematology, American Society of Clinical Oncology, Southwest Oncology Group, Multiple Myeloma and Special Populations Committees.
 
 
Representative Publications:
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close